Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion type Assertion NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_head.
- NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion description "[Combined neoadjuvant trastuzumab and docetaxel induced high clinical response rates for HER2-overexpressing breast cancer, in particular for inflammatory breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_provenance.
- NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion evidence source_evidence_literature NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_provenance.
- NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion SIO_000772 14715110 NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_provenance.
- NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion wasDerivedFrom befree-20140225 NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_provenance.
- NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_assertion wasGeneratedBy ECO_0000203 NP562168.RAZcFWZxLuy8Y9qrxOOBXRhGPUekTIao9KV7hTrHGcjGE130_provenance.